[HTML][HTML] Invasive lobular carcinoma of the breast: the increasing importance of this special subtype
AE McCart Reed, L Kalinowski, PT Simpson… - Breast Cancer …, 2021 - Springer
Invasive lobular carcinoma (ILC) is the most common of the breast cancer special types,
accounting for up to 15% of all breast cancer cases. ILCs are noted for their lack of E …
accounting for up to 15% of all breast cancer cases. ILCs are noted for their lack of E …
Immunohistochemistry for diagnosis and prognosis of breast cancer: a review
T Bonacho, F Rodrigues, J Liberal - Biotechnic & Histochemistry, 2020 - Taylor & Francis
Breast cancer is the most prevalent malignant tumor and main oncologic cause of mortality
in women. Although most diagnosis of breast pathology is accomplished using hematoxylin …
in women. Although most diagnosis of breast pathology is accomplished using hematoxylin …
[HTML][HTML] High-risk lesions of the breast: concurrent diagnostic tools and management recommendations
F Catanzariti, D Avendano, G Cicero… - Insights into …, 2021 - Springer
Breast lesions with uncertain malignant behavior, also known as high-risk or B3 lesions, are
composed of a variety of pathologies with differing risks of associated malignancy. While …
composed of a variety of pathologies with differing risks of associated malignancy. While …
Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect
Recent studies have reported germline CDH1 mutations in cases of lobular breast cancer
(LBC) not associated with the classical hereditary diffuse gastric cancer syndrome. A …
(LBC) not associated with the classical hereditary diffuse gastric cancer syndrome. A …
Pitfalls in breast pathology
C Quinn, A Maguire, E Rakha - Histopathology, 2023 - Wiley Online Library
Accurate pathological diagnosis is the cornerstone of optimal clinical management for
patients with breast disease. As non‐operative diagnosis has now become the standard of …
patients with breast disease. As non‐operative diagnosis has now become the standard of …
Management of high-risk breast lesions
M Bahl - Radiologic Clinics, 2021 - radiologic.theclinics.com
More than 10% of breast biopsies performed based on findings at mammography yield
highrisk lesions (HRLs). 1 HRLs refer to a group of heterogeneous lesions that can be …
highrisk lesions (HRLs). 1 HRLs refer to a group of heterogeneous lesions that can be …
Pre-operative management of pleomorphic and florid lobular carcinoma in situ of the breast: report of a large multi-institutional series and review of the literature
MP Foschini, R Miglio, R Fiore, C Baldovini… - European Journal of …, 2019 - Elsevier
Abstract Background Pleomorphic and Florid Lobular carcinoma in situ (P/F LCIS) are rare
variants of LCIS, the exact nature of which is still debated. Aim To collect a large series of …
variants of LCIS, the exact nature of which is still debated. Aim To collect a large series of …
[HTML][HTML] The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression
E-cadherin complexes with the actin cytoskeleton via cytoplasmic catenins and maintains
the functional characteristics and integrity of the epithelia in normal epithelial tissues. Lost …
the functional characteristics and integrity of the epithelia in normal epithelial tissues. Lost …
Benign breast papillary lesions diagnosed on core biopsy: upgrade rate and risk factors associated with malignancy on surgical excision
C MacColl, A Salehi, S Parpia, N Hodgson… - Virchows Archiv, 2019 - Springer
Abstract Evaluation of radiologically detected breast lesions is a common task in surgical
pathology. Some benign lesions on biopsy are associated with an upgrade to in situ or …
pathology. Some benign lesions on biopsy are associated with an upgrade to in situ or …
[HTML][HTML] Triple-negative breast cancer comparison with canine mammary tumors from light microscopy to molecular pathology
AA Namagerdi, D d'Angelo, F Ciani… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Many similar characteristics in human and dog cancers including, spontaneous
development, clinical presentation, tumor heterogeneity, disease progression, and response …
development, clinical presentation, tumor heterogeneity, disease progression, and response …